| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 27 | +81.48% | -4.94% | -0.07% | -4.86% | -6.52% | — |
| 14d | 27 | +59.26% | -5.49% | +0.14% | -5.63% | -6.43% | — |
| 30d | 27 | +62.96% | -8.62% | +0.29% | -8.91% | -8.74% | — |
| 60d | 27 | +51.85% | -8.73% | +1.95% | -10.68% | +1.89% | — |
| 90d | 27 | +59.26% | -8.47% | +3.43% | -11.89% | -19.06% | — |
| 180d | 27 | +59.26% | -1.70% | +7.46% | -9.15% | -18.04% | — |
| 1y | 27 | +37.04% | +0.01% | +19.02% | -19.01% | +2.80% | — |
| 2y | 27(10 pending) | +70.59% | -26.08% | +44.75% | -70.83% | -93.86% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| MLYS MINERALYS THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 104,124 | $25.90 | $2.70M | 38,400 | Jun 26, 2026 | Jun 30, 2026 ↗ | View → |
| MLYS MINERALYS THERAPEUTICS, INC. | SALE Chief Commercial Officer | 104,124 | — | — | 252,876 | Jun 26, 2026 | Jun 30, 2026 ↗ | View → |
| MLYS MINERALYS THERAPEUTICS, INC. | PURCHASE Chief Commercial Officer | 104,124 | $13.24 | $1.38M | 142,524 | Jun 26, 2026 | Jun 30, 2026 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 108 | $0.98 | $106 | 370,218 | Apr 17, 2025 | Apr 21, 2025 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 2,433 | $1.49 | $3.6K | 370,326 | Mar 18, 2025 | Mar 19, 2025 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 191,000 | — | — | 191,000 | Mar 14, 2025 | Mar 17, 2025 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 213,000 | — | — | 372,759 | Mar 14, 2025 | Mar 17, 2025 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 239 | $1.87 | $446 | 159,759 | Feb 19, 2025 | Feb 20, 2025 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 123 | $2.26 | $278 | 159,998 | Jan 17, 2025 | Jan 21, 2025 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 2,234 | $2.43 | $5.4K | 160,121 | Dec 17, 2024 | Dec 18, 2024 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 197 | $2.17 | $427 | 162,355 | Nov 19, 2024 | Nov 20, 2024 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 107 | $2.12 | $227 | 162,552 | Oct 17, 2024 | Oct 18, 2024 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 2,608 | $1.78 | $4.7K | 162,659 | Sep 17, 2024 | Sep 18, 2024 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 211 | $1.95 | $411 | 165,267 | Aug 19, 2024 | Aug 20, 2024 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 108 | $2.59 | $279 | 165,478 | Jul 17, 2024 | Jul 18, 2024 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 2,540 | $2.86 | $7.3K | 165,586 | Jun 18, 2024 | Jun 20, 2024 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 192 | $2.48 | $477 | 168,126 | May 17, 2024 | May 20, 2024 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 100,000 | — | — | 168,318 | Mar 14, 2024 | Mar 15, 2024 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 150,000 | — | — | 150,000 | Mar 14, 2024 | Mar 15, 2024 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 742 | $1.25 | $924 | 68,318 | Sep 20, 2023 | Sep 21, 2023 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 243 | $1.41 | $344 | 69,060 | Aug 18, 2023 | Aug 21, 2023 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 106 | $1.59 | $168 | 69,303 | Jul 19, 2023 | Jul 20, 2023 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 603 | $1.48 | $894 | 69,409 | Jun 21, 2023 | Jun 22, 2023 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 219 | $1.62 | $356 | 70,012 | May 17, 2023 | May 18, 2023 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 115 | $1.28 | $147 | 70,231 | Apr 19, 2023 | Apr 20, 2023 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 526 | $1.78 | $937 | 70,346 | Mar 17, 2023 | Mar 20, 2023 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 94,500 | — | — | 94,500 | Mar 14, 2023 | Mar 15, 2023 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 22,300 | — | — | 70,872 | Mar 14, 2023 | Mar 15, 2023 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 5,090 | $5.06 | $25.7K | 48,572 | Mar 7, 2023 | Mar 8, 2023 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 107 | $7.69 | $823 | 53,662 | Oct 18, 2022 | Oct 19, 2022 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 255 | $6.92 | $1.8K | 53,769 | Sep 19, 2022 | Sep 20, 2022 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASE Chief Commercial Officer | 1,000 | $7.46 | $7.5K | 54,024 | Aug 31, 2022 | Aug 31, 2022 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 199 | $6.82 | $1.4K | 53,024 | Aug 17, 2022 | Aug 18, 2022 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 431 | $6.58 | $2.8K | 53,223 | Jul 19, 2022 | Jul 20, 2022 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 256 | $4.90 | $1.3K | 53,654 | Jun 17, 2022 | Jun 21, 2022 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 52,000 | — | — | 52,000 | Jun 7, 2022 | Jun 9, 2022 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | SALE Chief Commercial Officer | 196 | $5.98 | $1.2K | 53,910 | May 17, 2022 | May 18, 2022 ↗ | View → |
| ESPR ESPERION THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 13,000 | — | — | 54,106 | Mar 14, 2022 | Mar 16, 2022 ↗ | View → |